Back
Dave & Buster's Entertainment Vs. Alnylam Pharmaceuticals Industry Stock Comparison
Sell
36
PLAY
Dave & Buster's Entertainment
Last Price:
$20.26
Seasonality Move:
25.12%
Buy
60
ALNY
Alnylam Pharmaceuticals
Last Price:
$280.77
Seasonality Move:
3.3%
Sell
36
Dave & Buster's Entertainment (PLAY)
is a Sell
Is Dave & Buster's Entertainment a Buy, Sell or Hold?
-
The current Dave & Buster's Entertainment [PLAY] share price is $21.16. The Score for PLAY is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
-
PLAY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
60
Alnylam Pharmaceuticals (ALNY)
is a Buy
Is Alnylam Pharmaceuticals a Buy, Sell or Hold?
-
The current Alnylam Pharmaceuticals [ALNY] share price is $290.70. The Score for ALNY is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
ALNY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
PLAY Stock Price Chart
What is Dave & Buster's Entertainment's stock price today?
-
The Dave & Buster's Entertainment share price today is $21.16Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and PLAY is experiencing buying pressure, which is a positive indicator for future bullish movement.
ALNY Stock Price Chart
What is Alnylam Pharmaceuticals's stock price today?
-
The Alnylam Pharmaceuticals share price today is $290.70Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ALNY is experiencing selling pressure, which indicates risk of future bearish movement.
PLAY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -1.33 | Sell |
Relative Strength Index (14 RSI): | 50.87 | Buy |
Chaikin Money Flow: | 850576 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (18.33 - 23.33) | Buy |
Bollinger Bands (100): | (22.34 - 36.1) | Sell |
ALNY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 3.72 | Buy |
Relative Strength Index (14 RSI): | 71.41 | Buy |
Chaikin Money Flow: | -979016 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (238.44 - 263) | Buy |
Bollinger Bands (100): | (240.32 - 271.8) | Buy |
PLAY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 18.95 | Buy |
20-day SMA: | 19.84 | Buy |
50-day SMA: | 23.77 | Sell |
200-day SMA: | 32.78 | Sell |
8-day EMA: | 19.59 | Buy |
20-day EMA: | 20.35 | Buy |
50-day EMA: | 23.44 | Sell |
200-day EMA: | 32.34 | Sell |
ALNY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 257.74 | Buy |
20-day SMA: | 249.75 | Buy |
50-day SMA: | 257.54 | Buy |
200-day SMA: | 251.5 | Buy |
8-day EMA: | 263.89 | Buy |
20-day EMA: | 256.08 | Buy |
50-day EMA: | 255.39 | Buy |
200-day EMA: | 243.44 | Buy |
Dave & Buster's Entertainment Earnings Growth & PLAY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.08 per share, an increase next quarter of $1.29 per share, a decrease this year of $0.88 per share, and an increase next year of $0.32 per share.
Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.91 per share, an increase next quarter of $0.05 per share, an increase this year of $1.08 per share, and an increase next year of $2.75 per share.
Dave & Buster's Entertainment Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Alnylam Pharmaceuticals Technical Analysis
Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |